International Journal of Prostate Cancer

About The Journal
 

Journal Overview

International Journal of Prostate Cancer (IJPC) is an open access, peer-reviewed, scholarly journal dedicated to providing up-to-date research and information on prostate cancer and related medical sciences. IJPC publishes original research articles, reviews, editorials and case reports on prostatic neoplasms and the treatment and management of prostate cancer. This journal offers a platform for researchers to share their knowledge on this important topic and to reach a worldwide audience.

IJPC provides readers with latest advances in prostate cancer management, including emerging treatments, new research and study results, and the latest diagnostic and therapeutic modalities. It also serves as a forum for debates, discussions, and reviews of recent publications. IJPC publishes original research, review articles, and short case reports, all of which are peer-reviewed and subject to rigorous editorial standards.

 

Advantages

Journal encourages authors to submit both original research and review articles, as well as special issues. The journal covers all aspects of prostate cancer, including its diagnosis, treatment, surveillance, and outcomes.

IJPC offers authors a wide range of benefits, such as a free copy of the journal, free access to the journals content and immediate publication upon acceptance. The journal is also committed to open peer review, with authors encouraged to share their data and ideas openly with peer reviewers. 

 

Instructions for author

Journal promotes the highest standards in scientific research and encourages authors to adhere to the Guidelines for Authors, which are based on the Committee on Publication Ethics (COPE) and International Committee of Medical Journal Editors (ICMJE) recommendations. Authors are expected to submit high quality manuscripts that represent significant advances in the medical field. All manuscripts should be written in English, include accurate references, and should not exceed 6000 words (excluding abstract, references and figures). Manuscripts should be submitted directly via the journal's submission system. 

 

Editorial Board 

The editorial team of IJPC is committed to providing authors with a speedy, fair and efficient review process. IJPC's Editorial Board consists of renowned experts in the field of prostate cancer. Each editorial board member is committed to ensure the highest quality of the journal’s content and the smooth reviewing process. The board also includes members from various countries with expertise in multiple aspects of prostate cancer research. 

 

Article Processing Charges

Authors are charged a minimal Article Processing Charge to cover both production and publication costs. These charges ensure that the journal can provide high-quality information to its readers. 

 

Submission Procedure

IJPC encourages submissions from clinicians, researchers, and industry representatives from all over the world. Submitted manuscripts are subjected to a single-blind review process and publication decisions are based on scientific merit. All published manuscripts are made available with open access which allows them to be widely read, downloaded, and cited. For information on submitting manuscripts, please visit the Submissions page.

 

The journal encourages submissions of original research papers, review papers, case reports, short communications and editorials that add to the understanding of prostate cancer. All the submitted papers will undergo a rigorous peer-review process by experienced and knowledgeable experts. IJPC is dedicated to presenting to its readers the most up-to-date information on the diagnosis and treatment of prostate cancer.